¼¼°èÀÇ »À ¼ºÀå Àڱر⠽ÃÀå - ºÐ¼®°ú ¿¹Ãø(-2033³â) : À¯Çü, Á¦Ç°, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ÄÄÆ÷³ÍÆ®, µð¹ÙÀ̽º, ÇÁ·Î¼¼½º, ¸ðµåº°
Bone Growth Stimulators Market Analysis and Forecast to 2033: Type, Product, Technology, Application, End User, Component, Device, Process, Mode
»óǰÄÚµå : 1633064
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 351 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,603,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 7,994,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,384,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ »À ¼ºÀå Àڱر⠽ÃÀåÀº 2023³â 18¾ï ´Þ·¯¿¡¼­ 2033³â 32¾ï ´Þ·¯·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ÀÇ CAGRÀº 6.0%·Î ÃßÁ¤µË´Ï´Ù.

»À ¼ºÀå Àڱر⠽ÃÀåÀº »ÀÀÇ ÀÚ¿¬ Ä¡À¯ °úÁ¤À» °­È­ÇÏ´Â Àåºñ¿Í Ä¡·á Àü¹® »ê¾÷À» Æ÷ÇÔÇÕ´Ï´Ù. ¿©±â¿¡´Â °ñÀý, ôÃß °íÁ¤, °ñ´Ù°øÁõÀ» Ä¡·áÇϵµ·Ï ¼³°èµÈ Àü±â, ÃÊÀ½ÆÄ ¹× ÀÚ±âÀå ÀڱرⰡ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀåÀº Á¤Çü¿Ü°ú Áúȯ Áõ°¡, ±â¼úÀÇ Áøº¸, ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ °ßÀεǾî ÇコÄÉ¾î ±â¼ú Çõ½Å°ú È®´ë¿¡ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

»À ¼ºÀå Àڱر⠽ÃÀåÀº °Ç°­ °ü¸® ±â¼úÀÇ Áøº¸¿Í »À °ü·Ã Áúº´ Áõ°¡·Î °ßÁ¶ÇÑ È®´ë¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. Àü±â »À ¼ºÀå Àڱرâ´Â ºñ ħ½ÀÀû ¼ºÁú°ú »À Ä¡À¯¸¦ ÃËÁøÇÏ´Â È¿°ú·Î ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ »À ¼ºÀå Àڱرâ´Â °ñÀý Ä¡À¯ °úÁ¤À» ÃËÁøÇÏ´Â ´É·Â¿¡ ÀÇÇØ °ßÀηÂÀ» ¾ò°í ÀÖÀ¸¸ç, µÎ ¹øÂ°·Î ³ôÀº ¼º°ú¸¦ ¿Ã¸®°í ÀÖ´Â ÇÏÀ§ ºÎ¹®À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, À̰ÍÀº ÀÌ Áö¿ªÀÇ ÇコÄɾî ÁöÃâÀÌ ¸¹°í ÀÇ·á±â±â ±â¼ú Áøº¸¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. À̾ À¯·´ÀÌ ¾à°£ Â÷À̰¡ ÀÖ¾î ¿¬±¸°³¹ß¿¡ ÈûÀ» ½ñ°í ÀÖÀ¸¸ç, °í·ÉÈ­ »çȸÀÇ ÁøÀüÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ª Áß ¹Ì±¹°ú µ¶ÀÏÀº È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í Á¤ºÎÀÇ Áö¿ø Á¤Ã¥À» ÅëÇØ ÁÖ¿ä °øÇå±¹ÀÌ µÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ ¾Æ½Ã¾ÆÅÂÆò¾çÀº À¯¸ÁÇÑ ÀáÀç·ÂÀ» º¸À̰í ÀÖÀ¸¸ç Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡µéÀº ÀÇ·á ÅõÀÚ Áõ°¡¿Í ¼±Áø ÀÇ·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¸¦ ¹è°æÀ¸·Î ±Þ¼ÓÇÑ ½ÃÀå ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

2023³â, »À ¼ºÀå ÀÚ±Ø ½ÃÀåÀº ´Ù¾çÇÑ ¼¼ºÐÈ­À» Ư¡À¸·Î Çϸç, Àü±âÀû »À ¼ºÀå ÀڱرⰡ 45% ½ÃÀå Á¡À¯À²·Î Áö¹èÀûÀÔ´Ï´Ù. ÃÊÀ½ÆÄ »À ¼ºÀå ÀڱرⰡ 35% Á¡À¯À²·Î À̾îÁö¸ç º¹ÇÕÀÚÀåÀåÄ¡°¡ 20%¸¦ Â÷ÁöÇÕ´Ï´Ù. ½ÃÀå ±Ô¸ð´Â °ñ°ü·Ã Áúȯ Áõ°¡¿Í ±â¼ú Áøº¸·Î 2023³â 120¸¸´ë¿¡¼­ 2033³â 200¸¸´ë·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Orthofix Holdings, DJO Global, Zimmer Biomet µî ÁÖ¸ñÇÒ¸¸ÇÑ ±â¾÷ÀÌ Áß½ÉÀû Á¸ÀçÀ̸ç, Çõ½ÅÀ» Ȱ¿ëÇÏ¿© ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù.

°æÀï·Â ´ÙÀ̾î±×·¥Àº Àü·«Àû M&A¿¡ ÀÇÇØ Çü¼ºµÇ°í Zimmer Biomet¿Í °°Àº ±â¾÷Àº ¸ñÇ¥¸¦ ÀâÀº Àμö·Î Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. FDA ½ÂÀÎ ¹× CE ¸¶Å·°ú °°Àº ±ÔÁ¦ÀÇ ¿µÇâÀº ¸Å¿ì Áß¿äÇÏ¸ç ½ÃÀå ÁøÀÔ°ú Á¦Ç° ¼ö¸íÁֱ⸦ Á¿ìÇÕ´Ï´Ù. ±×·¯³ª ³ôÀº ÀÇ·á Àåºñ ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¦ »óȲ°ú °°Àº ¹®Á¦´Â ¿©ÀüÈ÷ ³²¾Æ ÀÖÀ¸¸ç Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§Çؼ­´Â Àü·«Àû ÀûÀÀÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ºÏ¹Ì´Â Á¤Çü¿Ü°ú ÁúȯÀÇ ³ôÀº À¯º´·ü°ú °í±Þ °Ç°­ °ü¸® ÀÎÇÁ¶ó·Î °ßÀÎµÇ¾î »À ¼ºÀå Àڱر⠽ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç ÀÌ Áö¿ªÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç°¡ ±× ÁöÀ§¸¦ ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÌ ÀÌ¿¡ ÀÌ¾î µ¶Àϰú ¿µ±¹ µîÀÌ Å©°Ô °øÇåÇϰí ÀÖ½À´Ï´Ù. ÀÌ ³ª¶óµéÀº ±â¼ú Áøº¸¿Í °Ç°­ °ü¸® ÁöÃâ¿¡ ÁßÁ¡À» µÓ´Ï´Ù. À¯·´ÀÇ °í·ÉÈ­µµ »À ¼ºÀå Àڱر⠼ö¿ä¸¦ ÃËÁøÇÏ°í ½ÃÀå È®´ëÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº À¯¸ÁÇÑ ¼ºÀå °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡¿¡¼­´Â °Ç°­ °ü¸®¿¡ ´ëÇÑ ÁöÃâ°ú ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í ÀÇ·á ½Ã¼³ÀÇ Ãæ½ÇÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ Àα¸ ±â¹ÝÀÇ Å©±â´Â ½ÃÀå ħÅõÀÇ Å« ±âȸÀÔ´Ï´Ù.

¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«Àº ¿Ï¸¸ÇÑ ¼ºÀåÀ» º¸¿©ÁÝ´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó °³¼±À¸·Î ºê¶óÁúÀÌ À̲ø°í ÀÖ½À´Ï´Ù. Áßµ¿ ±¹°¡µéÀº ÀÇ·á Áøº¸¿¡ ÅõÀÚÇϰí ÀÖÁö¸¸ ½ÃÀåÀº ¿©ÀüÈ÷ Ãʱ⠴ܰ迡 ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ÀÌ·¯ÇÑ Áö¿ªÀº ¾ÕÀ¸·Î ¸î ³âµ¿¾È ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» ±â´ëÇÒ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå »À ¼ºÀå Àڱر⠽ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ Áß¿ä ÀλçÀÌÆ®

Á¦4Àå »À ¼ºÀå Àڱر⠽ÃÀå Àü¸Á

Á¦5Àå »À ¼ºÀå Àڱر⠽ÃÀå Àü·«

Á¦6Àå »À ¼ºÀå Àڱر⠽ÃÀå ±Ô¸ð

Á¦7Àå »À ¼ºÀå Àڱر⠽ÃÀå : À¯Çüº°

Á¦8Àå »À ¼ºÀå Àڱر⠽ÃÀå : Á¦Ç°º°

Á¦9Àå »À ¼ºÀå Àڱر⠽ÃÀå : ±â¼úº°

Á¦10Àå »À ¼ºÀå Àڱر⠽ÃÀå : ¿ëµµº°

Á¦11Àå »À ¼ºÀå Àڱر⠽ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦12Àå »À ¼ºÀå Àڱر⠽ÃÀå : ÄÄÆ÷³ÍÆ®º°

Á¦13Àå »À ¼ºÀå Àڱر⠽ÃÀå : µð¹ÙÀ̽ºº°

Á¦14Àå »À¼ºÀåÀڱر⠽ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦15Àå »À ¼ºÀå Àڱر⠽ÃÀå : ¸ðµåº°

Á¦16Àå »À ¼ºÀå Àڱر⠽ÃÀå :Áö¿ªº°

Á¦17Àå °æÀï ±¸µµ

Á¦18Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The bone growth stimulators market is anticipated to expand from $1.8 billion in 2023 to $3.2 billion by 2033, with a CAGR of 6.0% over the forecast period.

The Bone Growth Stimulators Market encompasses the industry dedicated to devices and therapies that enhance the natural healing process of bones. These include electrical, ultrasonic, and magnetic field stimulators, designed to treat fractures, spinal fusions, and osteoporosis. The market is driven by rising orthopedic conditions, technological advancements, and increasing demand for non-invasive treatments, offering significant opportunities for innovation and expansion in healthcare.

The Bone Growth Stimulators Market is witnessing robust expansion, driven by advancements in healthcare technologies and increasing incidences of bone-related disorders. Electrical bone growth stimulators lead the market, owing to their non-invasive nature and effectiveness in enhancing bone healing. Ultrasound bone growth stimulators emerge as the second-highest performing sub-segment, gaining traction due to their ability to accelerate fracture healing processes. Geographically, North America dominates the market, attributed to the region's high healthcare expenditure and technological advancements in medical devices. Europe follows closely, with a strong focus on research and development and a growing aging population contributing to market growth. Within these regions, the United States and Germany are key contributors, due to their established healthcare infrastructure and supportive government policies. Additionally, the Asia-Pacific region shows promising potential, with countries like China and India experiencing rapid market growth, driven by increasing healthcare investments and rising awareness of advanced medical treatments.

In 2023, the Bone Growth Stimulators Market is characterized by a diverse segmentation, with electrical bone growth stimulators dominating at 45% market share. Ultrasound bone growth stimulators follow with a 35% share, and combined magnetic field devices account for 20%. The market volume is anticipated to escalate from 1.2 million units in 2023 to 2 million units by 2033, driven by rising incidences of bone-related disorders and technological advancements. Notable players such as Orthofix Holdings, DJO Global, and Zimmer Biomet are pivotal, leveraging innovations to sustain their market positions.

Competitive dynamics are shaped by strategic mergers and acquisitions, with companies like Zimmer Biomet expanding their portfolios through targeted acquisitions. Regulatory influences, including FDA approvals and CE markings, are critical, dictating market entry and product lifecycle. However, challenges such as high device costs and stringent regulatory landscapes persist, necessitating strategic adaptability for sustained growth.

North America dominates the bone growth stimulators market, driven by a high prevalence of orthopedic conditions and advanced healthcare infrastructure. The United States leads the region due to significant investments in research and development. The presence of major market players further strengthens its position.

Europe follows closely, with countries like Germany and the United Kingdom contributing significantly. These countries emphasize technological advancements and healthcare expenditure. The aging population in Europe also fuels demand for bone growth stimulators, creating lucrative opportunities for market expansion.

The Asia Pacific region exhibits promising growth potential. Countries such as China and India are experiencing increased healthcare spending and awareness. Rapid urbanization and improving healthcare facilities further support market growth. The region's large population base presents a considerable opportunity for market penetration.

Latin America and the Middle East & Africa regions show moderate growth. In Latin America, Brazil leads due to improving healthcare infrastructure. Middle Eastern countries are investing in healthcare advancements, although the market remains in its nascent stages. Overall, these regions are expected to witness steady growth in the coming years.

Key Companies

Orthofix International, Bioventus, Zimmer Biomet, DJO Global, Medtronic, Stryker, Ossatec Benelux, IGEA, BTT Health, Stimulate Health, Elizur, Altis Biologics, Verve Consulting, Cerapedics, Fintek Bio- Electro, Magstim, Theragen, Neurotech, Regen Lab, Osteo Med

Sources

U.S. Food and Drug Administration, European Medicines Agency, National Institutes of Health, World Health Organization, Centers for Disease Control and Prevention, American Academy of Orthopaedic Surgeons, International Society for Clinical Densitometry, International Osteoporosis Foundation, National Institute for Health and Care Excellence, U.S. Department of Health and Human Services, European Federation of National Associations of Orthopaedics and Traumatology, Orthopaedic Research Society, American Association of Orthopaedic Surgeons Annual Meeting, International Conference on Orthopaedics and Traumatology, World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, International Society for Technology in Arthroplasty, American Society for Bone and Mineral Research, European Calcified Tissue Society, University of California, San Francisco - Orthopaedic Surgery Department

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Bone Growth Stimulators Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Bone Growth Stimulators Market Outlook

5: Bone Growth Stimulators Market Strategy

6: Bone Growth Stimulators Market Size

7: Bone Growth Stimulators Market, by Type

8: Bone Growth Stimulators Market, by Product

9: Bone Growth Stimulators Market, by Technology

10: Bone Growth Stimulators Market, by Application

11: Bone Growth Stimulators Market, by End User

12: Bone Growth Stimulators Market, by Component

13: Bone Growth Stimulators Market, by Device

14: Bone Growth Stimulators Market, by Process

15: Bone Growth Stimulators Market, by Mode

16: Bone Growth Stimulators Market, by Region

17: Competitive Landscape

18: Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â